Daily non-political popular news in brief.

Study finds that blood test can gauge prostate cancer risk

New genomics research has found that a simple blood test can determine which men are likely to develop prostate cancer. Researchers at Wake Forest University School of Medicine and colleagues found that five genetic variants previously associated with prostate cancer risk have a strong cumulative effect.

Read more »

Keywords: study, blood, test, gauge, prostate, cancer, risk

« Previous | Next »

Similar news on "Study finds that blood test can gauge prostate cancer risk":

1. Genetic marker linked to aggressive prostate cancer
   05-20-2007 · EurekAlert!
   Northwestern University researchers have discovered that a recently identified genetic marker for prostate cancer is linked to a highly aggressive form of the disease. These findings ultimately will aid the development of a simple blood test to predict who is susceptible to this aggressive cancer. Knowing which patients carry this genetic marker also will guide doctors in how they treat the cancer. The study showed a strong hereditary component to this aggressive cancer.
   Similar news · Read more »
   
2. Obesity-linked high blood volumes render PSA prostate cancer test less effective, study suggests
   11-20-2007 · EurekAlert!
   The extra blood volume produced in the obese may so dilute levels of a telltale protein produced by prostates that the popular PSA test may be essentially useless for diagnosing prostate cancer in men carrying extra pounds, a new study in the Journal of the American Medical Association suggests.
   Similar news · Read more »
   
3. PSA doubling predicts prostate cancer recurrence
   04-09-2007 · EurekAlert!
   A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical prostatectomy. In a new Mayo Clinic study, the concept of PSA doubling time is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for disease recurrence and death from prostate cancer. Doubling time is defined as the duration for PSA levels in the blood to increase by 100 percent.
   Similar news · Read more »
   
4. Elderly, ill men get unneeded prostate cancer screenings
   11-14-2006 · EurekAlert!
   A study of almost 600,000 men aged 70 and older reveals that 56 percent had a routine prostate-specific antigen screening, a blood test for prostate cancer, even though no treatment guidelines recommend PSA screening for men of that age.
   Similar news · Read more »
   
5. Study identifies multiple genetic risk factors for prostate cancer
   04-01-2007 · EurekAlert!
   A study led by researchers at the Keck School of Medicine of the University of Southern California and Harvard Medical School has identified seven genetic risk factors that predict risk for prostate cancer. According to the study's findings, these risk factors are clustered in a single region of the human genome on chromosome 8 and powerfully predict a man's probability of developing prostate cancer.
   Similar news · Read more »
   
6. New Jefferson trial to test radiation-emitting beads against advanced liver cancer
   02-12-2008 · EurekAlert!
   Liver cancer specialists at Jefferson's Kimmel Cancer Center in Philadelphia are beginning an 18-month study of a new treatment for liver cancer. The therapy entails injecting tiny beads that emit small amounts of radiation into the liver's main artery while also blocking the blood supply feeding the cancer’s growth.
   Similar news · Read more »
   
7. Preventing graft-versus-host disease disease after bone marrow transplant -- without toxicity
   12-11-2006 · EurekAlert!
   Most patients undergoing bone-marrow transplant must receive powerful chemotherapy drugs to suppress their immune system and prevent their bodies from rejecting the donated cells. New research shows that this chemotherapy increases the risk for graft-versus-host disease -- but also suggests that this risk can be reduced by replacing a natural antibiotic that's depleted when patients undergo chemotherapy. A multicenter study led by Children's Hospital Boston and the Dana-Farber Cancer Institute is about to test this idea.
   Similar news · Read more »
   
8. Mailman School of Public Health researchers report blood DNA can be early predictor of liver cancer
   04-15-2007 · EurekAlert!
   Researchers at Columbia University's Mailman School of Public Health have discovered a means for early detection of liver cancer. Using DNA isolated from serum samples as a baseline biomarker, the scientists examined changes in certain tumor suppressor genes that have been associated with the development of liver carcinomas. This is the first study to prospectively examine potential biomarkers for early detection of liver cancer in high-risk populations.
   Similar news · Read more »
   
9. Blood test may help signal tumor's remission, return in throat cancer patients
   06-01-2007 · EurekAlert!
   A blood test that detects proteins commonly released by a growing tumor could one day become a useful tool for monitoring the effectiveness of chemotherapy and radiation treatment in people with advanced throat cancer, according to a study published in the June 1, 2007, issue of Clinical Cancer Research.
   Similar news · Read more »
   
10. Other highlights in the Dec. 11 JNCI
    12-11-2007 · EurekAlert!
    Also in the Dec. 11 JNCI are a drug that may reduce breast cancer recurrence, the risk of cancer after a blood transfusion, the association between PSA testing and prostate cancer diagnoses, and cancer risk among NBN mutation carriers.
    Similar news · Read more »